Lipid Profile in Patients of Type 2 Diabetes Mellitus with and Without Hypertension at Rehman Medical Institute Peshawar

Amna Khattak; Mirza Muhammad Dawood; Muhammad Yasir Jan; Safia Rahman; Attaullah; Ijaz Aziz

doi:10.70749/ijbr.v3i3.2202

Authors

Amna Khattak Department of Chemical Pathology, Rehman Medical Institute, Peshawar, KP, Pakistan.
Mirza Muhammad Dawood Department of Chemical Pathology, Rehman Medical Institute, Peshawar, KP, Pakistan.
Muhammad Yasir Jan Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.
Safia Rahman Department of Chemical Pathology, Rehman Medical Institute, Peshawar, KP, Pakistan.
Attaullah Department of Community Medicine, Mekran Medical College Turbat, Pakistan.
Ijaz Aziz Department of Forensic Medicine, Mekran Medical College Turbat, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i3.2202

Keywords:

Diabetes Mellitus Type 2, Dyslipidaemia, Hypertension.

Abstract

Introduction: Type 2 diabetes Patients often causes dyslipidemia, which is marked by high triglycerides, low HDL cholesterol, and dense LDL particles. High triglycerides, free fatty acids, and HDL cholesterol promote dyslipidemia-related cardiovascular problems. Objectives: To determine the prevalence and relation of dyslipidemia with Type 2 diabetes Patients mellitus in patients with or without hypertension. Materials & Methods: This 400-person cross-sectional study was done at Rehman Medical Institute from December 2023 to June 2024. The study included both men and women with type 2 diabetes Patients for more than five years and aged 40 or older. Data were analyzed with SPSS v20. Categorical variables were calculated using frequencies and percentages, whereas quantitative variables were represented by mean and standard deviation. The difference between and within groups was assessed using an independent samples t-test. P-value less than 0.05 was statistically significant. Results: Among 400 patients, 240 were female and 160 males. Most patients, 140, were 51-60 years old, 35% of the total. The second biggest number of patients was 41-50 years old, while the fewest were 71-80 years old. The patients had an average age of 50.95 ±5.86. The cases had average cholesterol, triglycerides, and LDL values of 210.90, 308.05, and 116.04 mg/dL. The controls had average values of 159.08, 153.99, and 96.01 mg/dL. The serum cholesterol, triglyceride, and LDL levels were statistically significant (p < 0.05). Conclusion: Hyperlipidaemia is common in patients with type 2 diabetes Patients and hypertension. We identified significant differences in cholesterol, triglyceride, LDL, and HDL levels between the two groups. HDL differences were not significant.

Downloads

Download data is not yet available.

References

1. Daly, A., Sapra, A., Albers, C. E., Dufner, A. M., & Bhandari, P. (2021). Food insecurity and diabetes: The role of Federally qualified health centers as pillars of community health. Cureus.

https://doi.org/10.7759/cureus.13841

2. Smith‐Miller, C. A., Berry, D. C., & Miller, C. T. (2017). Diabetes affects everything: Type 2 diabetes self‐management among Spanish‐speaking Hispanic immigrants. Research in Nursing & Health, 40(6), 541-554.

https://doi.org/10.1002/nur.21817

3. Oguntibeju, O. O. (2019). Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. International journal of physiology, pathophysiology and pharmacology, 11(3), 45.

https://pmc.ncbi.nlm.nih.gov/articles/PMC6628012/

4. DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., Simonson, D. C., Testa, M. A., & Weiss, R. (2015). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1(1).

https://doi.org/10.1038/nrdp.2015.19

5. Basit, A., Fawwad, A., Qureshi, H., & Shera, A. S. (2018). Prevalence of diabetes, pre-diabetes and associated risk factors: Second National Diabetes survey of Pakistan (NDSP), 2016–2017. BMJ Open, 8(8), e020961.

https://doi.org/10.1136/bmjopen-2017-020961

6. Akhtar, S., Nasir, J. A., Abbas, T., & Sarwar, A. (2019). Diabetes in Pakistan: A systematic review and meta-analysis. Pakistan Journal of Medical Sciences, 35(4).

https://doi.org/10.12669/pjms.35.4.194

7. Halim, M., & Halim, A. (2019). The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(2), 1165-1172.

https://doi.org/10.1016/j.dsx.2019.01.040

8. Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3(1).

https://doi.org/10.1038/nrdp.2017.16

9. Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018). The pathophysiology of gestational diabetes mellitus. International Journal of Molecular Sciences, 19(11), 3342.

https://doi.org/10.3390/ijms19113342

10. Tomkin, G., & Owens, D. (2017). Diabetes and dyslipidemia: Characterizing lipoprotein metabolism. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10, 333-343.

https://doi.org/10.2147/dmso.s115855

11. Schofield, J. D., Liu, Y., Rao-Balakrishna, P., Malik, R. A., & Soran, H. (2016). Diabetes Dyslipidemia. Diabetes Therapy, 7(2), 203-219.

https://doi.org/10.1007/s13300-016-0167-x

12. Matsuda, M., & Shimomura, I. (2013). Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obesity Research & Clinical Practice, 7(5), e330-e341.

https://doi.org/10.1016/j.orcp.2013.05.004

13. Papatheodorou, K., Papanas, N., Banach, M., Papazoglou, D., & Edmonds, M. (2016). Complications of diabetes 2016. Journal of Diabetes Research, 2016, 1-3.

https://doi.org/10.1155/2016/6989453

14. Sampani, E., Sarafidis, P., & Papagianni, A. (2020). Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: Epidemiology, pathophysiology, and treatment. Expert Opinion on Drug Safety, 19(6), 673-682.

https://doi.org/10.1080/14740338.2020.1764532

15. Mezil, S. A., & Abed, B. A. (2021). Complication of diabetes mellitus. Annals of the Romanian Society for Cell Biology, 25(3), 1546-1556.

16. Parekh, J., Corley, D., & Feng, S. (2012). Diabetes, hypertension and hyperlipidemia: Prevalence over time and impact on long-term survival after liver transplantation. American Journal of Transplantation, 12(8), 2181-2187.

https://doi.org/10.1111/j.1600-6143.2012.04077.x

17. Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., Rosendorff, C., & Yancy, C. (2016). Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: A scientific statement from the American Heart Association. Circulation, 134(23).

https://doi.org/10.1161/cir.0000000000000450

18. Dietrich, S., Floegel, A., Weikert, C., Prehn, C., Adamski, J., Pischon, T., Boeing, H., & Drogan, D. (2016). Identification of serum metabolites associated with incident hypertension in the European prospective investigation into cancer and Nutrition–Potsdam study. Hypertension, 68(2), 471-477.

https://doi.org/10.1161/hypertensionaha.116.07292

19. Johnson, M. L., Pietz, K., Battleman, D. S., & Beyth, R. J. (2006). Therapeutic goal attainment in patients with hypertension and Dyslipidemia. Medical Care, 44(1), 39-46.

https://doi.org/10.1097/01.mlr.0000188982.25397.37

20. Ni, W., Liu, X., Zhuo, Z., Yuan, X., Song, J., Chi, H., & Xu, J. (2015). Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids in Health and Disease, 14(1).

https://doi.org/10.1186/s12944-015-0073-7

21. Arshad, A. R., Tipu, H. N., & Paracha, A. I. (2016). The impact of hypertension on lipid parameters in type 2 diabetes. JPMA, 66(10), 1262-1266.

22. Balint, G. S., Iovanescu, G., Stanca, H., Popoiu, C. M., Boia, E., Popovici, R. A., & Bolintineanu, S. L. (2017). The protective effect of HDL-cholesterol in patients with essential hypertension. Revista de Chimie, 68(5), 949-952.

https://doi.org/10.37358/rc.17.5.5587

23. Alam S, Ali S, Khalil M, Deb K, Ahmed A, Akhter KJMMJM. Serum lipid profile in hypertensive and normotensive type II diabetes mellitus patients--a comparative study. 2003;12(1):13-6.

24. Gordon, L., Ragoobirsingh, D., Morrison, E. Y., Choo-Kang, E., McGrowder, D., & Martorell, E. (2010). Lipid profile of type 2 diabetic and hypertensive patients in the Jamaican population. Journal of Laboratory Physicians, 2(01), 025-030.

https://doi.org/10.4103/0974-2727.66709